Heinze H G, Pfeifer K J, Lichtenstein Z
Dtsch Med Wochenschr. 1975 Oct 24;100(43):2203-8. doi: 10.1055/s-0028-1106523.
Between 1963 and 1971, radioiodine (133I) treatment of a toxic thyroid adenoma was performed in 229 patients, in 70% the dosage being 30000 rd. In 188 patients the results were checked an average of 2 1/2 years later. Subjective improvement or freedom from symptoms was achieved in 76% (in 85% within 3-6 months), body weight increased, serum cholesterol level rose significantly, while pulse rate, pulse amplitude, PB127I and index of free thyroid hormones significantly fell. The 131I two-phase test was inconclusive. 72% of toxic adenomas were inactivated and 88% of patients with still active adenomas were improved or free from symptoms. Clinical improvement apparently preceded the scanning results. Corresponding to the index of free thyroid hormones, 94% were euthyroid, 0.6% hyperthroid, and 2.8% suspected of being hypothryoid. In combination with other findings, especially isotope scanning, 1.7% of patients were suspected of having T3 hyperthyroidism after treatment. A recurrence was observed in 2.1%. The success rate increased with rising radiation dose up to 30000 rd.
1963年至1971年间,对229例毒性甲状腺腺瘤患者进行了放射性碘(133I)治疗,70%的患者剂量为30000拉德。188例患者在平均2年半后进行了结果检查。76%的患者主观症状改善或无症状(85%在3至6个月内),体重增加,血清胆固醇水平显著上升,而脉搏率、脉搏振幅、PB127I和游离甲状腺激素指数显著下降。131I两阶段试验结果不明确。72%的毒性腺瘤失活,88%仍有活性腺瘤的患者症状改善或无症状。临床改善显然先于扫描结果。根据游离甲状腺激素指数,94%的患者甲状腺功能正常,0.6%甲状腺功能亢进,2.8%疑似甲状腺功能减退。结合其他检查结果,尤其是同位素扫描,1.7%的患者治疗后疑似患有T3甲亢。观察到2.1%的患者复发。辐射剂量增至30000拉德时成功率提高。